Co-delivery of everolimus and vinorelbine via a tumor-targeted liposomal formulation inhibits tumor growth and metastasis in RCC. [electronic resource]
Producer: 20190927Description: 5109-5123 p. digitalISSN:- 1178-2013
- Animals
- Carcinoma, Renal Cell -- drug therapy
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Drug Compounding
- Drug Delivery Systems -- methods
- Everolimus -- administration & dosage
- Humans
- Ki-67 Antigen -- metabolism
- Kidney Neoplasms -- drug therapy
- Liposomes
- Lung Neoplasms -- secondary
- Mice, SCID
- Phosphatidylethanolamines -- chemistry
- Polyethylene Glycols -- chemistry
- Tissue Distribution
- Vinorelbine -- administration & dosage
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.